Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
MC2 Therapeutics' psoriasis drug succeeds in Phase 3 trial
Biopharma Dive
Wed, 08/22/18 - 05:50 pm
MC2 Therapeutics
clinical trials
psoriasis
MC2-01
Taclonex
Dermavant inks $330M deal for GSK's phase 3-ready psoriasis drug
Fierce Biotech
Thu, 07/12/18 - 06:17 pm
GSK
Dermavant
Roivant
CSO
tapinarof
psoriasis
atopic dermatitis
Skin treatment device-maker Clarify Medical raises $1m
Mass Device
Thu, 07/5/18 - 07:57 pm
Clarify Medical
devices
psoriasis
Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion
Marketwatch
Mon, 06/18/18 - 09:52 am
Valeant Pharmaceuticals
psoriasis
FDA
Duobrii
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
CP Wire
Wed, 06/13/18 - 10:19 pm
JNJ
NICE
Tremfya
psoriasis
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
Wed, 06/13/18 - 10:19 pm
JNJ
Tremfya
psoriasis
Two drugs in the pipeline representing unique marketing challenges
Medical Marketing and Media
Tue, 06/5/18 - 10:37 pm
valrox
Biomarin
hepatitis A
risankizumab
AbbVie
Boehringer Ingelheim
psoriasis
US approves UCB’s Cimzia for psoriasis
Pharma Times
Tue, 05/29/18 - 09:16 pm
FDA
UCB Pharma
Cimzia
psoriasis
AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis
CP Wire
Tue, 05/1/18 - 09:25 pm
AbbVie
EMA
Europe
risankizumab
psoriasis
AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis
Tue, 05/1/18 - 10:08 am
AbbVie
psoriasis
risankizumab
UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis
CP Wire
Sat, 04/28/18 - 11:56 am
UCB Pharma
CHMP
Cimzia
psoriasis
UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis
Sat, 04/28/18 - 11:55 am
UCB Pharmaceuticals
Cimzia
psoriasis
Will Ilumya Kill Valeant's Psoriasis Dreams?
Seeking Alpha
Wed, 04/18/18 - 07:27 pm
Sun Pharma
Ilumya
FDA
psoriasis
Siliq
Valeant Pharmaceuticals
Sun Pharma Receives Approval for New Plaque Psoriasis Drug
CP Wire
Wed, 03/21/18 - 10:25 am
Sun Pharma
psoriasis
Ilumya
FDA
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
Endpoints
Tue, 03/13/18 - 09:31 pm
immunotherapy
psoriasis
Escalier
R&D
Novartis beefs up its data bank on Cosentyx’s durable effect on quality of life as well as scalp psoriasis
Endpoints
Fri, 02/16/18 - 09:32 pm
Novartis
Cosentyx
psoriasis
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Novartis
JNJ
psoriasis
Cosentyx
Stelara
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Yahoo/Zacks.com
Wed, 01/10/18 - 10:18 am
Novartis
psoriasis
Cosentyx
biosimilars
ankylosing spondylitis
In a crowded market, AbbVie may still have a best-in-class psoriasis prospect up its sleeve: analyst
Fierce Pharma
Wed, 12/6/17 - 09:53 am
AbbVie
psoriasis
risankizumab
JNJ
Tremfya
AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment
Marketwatch
Mon, 12/4/17 - 09:48 am
AbbVie
psoriasis
risankizumab
clinical trials
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »